A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Abroad (travel likely)RecruitingPHASE1
Conditions
Primary Membranous Nephropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, He'nan, China
Hebei General Hospital, Shijiazhuang, Hebei, China
The First Affiliated Hospital,College of Medicine,Zhejiang University, Hangzhou, Zhejiang, China
Peking university first hospital, Beijing, China
Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China
Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China